Neuren Pharmaceuticals Limited(NURPF)
$13.760.00 (0.00%)
NURPF
Neuren Pharmaceuticals Limited financials statements
$13.76
At close:0.00 (0.00%)
Neuren Pharmaceuticals Limited (NURPF) Ratios
55 Followers
Neuren Pharmaceuticals Limited Ratios
NURPF's free cash flow for Q2 2026 was AU$7.99M. For the 2026 fiscal year, NURPF's free cash flow was decreased by AU$-8.00K and operating cash flow was AU$8.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 76.60 | 8.73 | 5.78 | 25.77 | 49.87 |
| Quick Ratio | 76.60 | 8.73 | 5.78 | 25.77 | 49.87 |
| Cash Ratio | 0.97 | 0.07 | 0.40 | 23.95 | 45.81 |
| Solvency Ratio | 6.91 | 3.10 | 3.67 | 0.12 | -9.70 |
| Operating Cash Flow Ratio | 28.92 | -0.25 | 4.32 | 2.14 | -12.42 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ 327.83M | AU$ 353.52M | AU$ 204.39M | AU$ 41.57M | AU$ 39.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.01 | 1.13 | 1.21 | 1.04 | 1.02 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.19 | -0.02 | -0.09 | 59.97 | 3.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 99.96% | 99.99% | 88.47% | 99.93% | 99.75% |
| EBIT Margin | 34.07% | 82.32% | 85.89% | -4.67% | -343.79% |
| EBITDA Margin | 34.11% | 82.33% | 85.92% | -4.60% | -343.54% |
| Operating Profit Margin | 34.07% | 82.32% | 74.37% | -10.97% | -357.52% |
| Pretax Profit Margin | 60.23% | 85.79% | 88.45% | -4.67% | -343.79% |
| Net Profit Margin | 47.09% | 66.61% | 67.73% | 1.26% | -243.79% |
| Continuous Operations Profit Margin | 47.09% | 66.61% | 67.73% | 1.26% | -243.79% |
| Net Income Per EBT | 78.18% | 77.64% | 76.57% | -27.06% | 70.91% |
| EBT Per EBIT | 176.76% | 104.21% | 118.93% | 42.61% | 96.16% |
| Return on Assets (ROA) | 8.88% | 34.67% | 63.35% | 0.43% | -19.46% |
| Return on Equity (ROE) | 8.99% | 39.03% | 76.55% | 0.44% | -19.86% |
| Return on Capital Employed (ROCE) | 6.51% | 48.24% | 84.06% | -3.84% | -29.12% |
| Return on Invested Capital (ROIC) | 5.09% | 37.45% | 64.37% | 1.04% | -20.65% |
| Return on Tangible Assets | 8.88% | 34.67% | 63.35% | 0.43% | -19.46% |
| Earnings Yield | 1.28% | 8.89% | 4.98% | 0.02% | -1.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.44 | 1.23 | 16.09 | 13.36 | 2.25 |
| Payables Turnover | 0.03 | 0.02 | 39.63 | 0.04 | 0.03 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1436.31 | 6878.81 | 5393.60 | 693.00 | 266.42 |
| Asset Turnover | 0.19 | 0.52 | 0.94 | 0.34 | 0.08 |
| Working Capital Turnover Ratio | 0.19 | 0.76 | 1.89 | 0.36 | 0.10 |
| Cash Conversion Cycle | -13767.72 | -23744.26 | 13.47 | -9389.69 | -11015.55 |
| Days of Sales Outstanding | 149.89 | 295.96 | 22.68 | 27.31 | 162.58 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 13917.61 | 24040.23 | 9.21 | 9417.00 | 11178.13 |
| Operating Cycle | 149.89 | 295.96 | 22.68 | 27.31 | 162.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.98 | -0.09 | 1.46 | 0.03 | -0.08 |
| Free Cash Flow Per Share | 0.98 | -0.09 | 1.45 | 0.03 | -0.08 |
| Dividend Paid and CapEx Coverage Ratio | 3389.78 | -1127.00 | 4623.13 | 189.42 | -997.00 |
| Capital Expenditure Coverage Ratio | 3389.78 | -1127.00 | 4623.13 | 189.42 | -997.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 1.94 | -0.05 | 0.80 | 0.25 | -3.12 |
| Free Cash Flow Yield | 5.25% | -0.71% | 5.86% | 0.36% | -2.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 77.54 | 11.26 | 20.08 | 5442.54 | -56.97 |
| Price-to-Sales (P/S) Ratio | 36.92 | 7.49 | 13.60 | 68.81 | 138.88 |
| Price-to-Book (P/B) Ratio | 7.05 | 4.39 | 15.37 | 24.08 | 11.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.03 | -141.59 | 17.06 | 279.73 | -44.49 |
| Price-to-Operating Cash Flow Ratio | 19.03 | -141.71 | 17.05 | 278.25 | -44.53 |
| Price-to-Earnings Growth (PEG) Ratio | -0.99 | -1.07 | 0.00 | -53.22 | 2.48 |
| Enterprise Value Multiple | 108.06 | 9.08 | 15.74 | -1434.70 | -37.08 |
| Enterprise Value | 2.38B | 1.59B | 3.14B | 961.25M | 407.21M |
| EV to EBITDA | 108.06 | 9.08 | 15.74 | -1434.70 | -37.08 |
| EV to Sales | 36.86 | 7.47 | 13.52 | 66.05 | 127.37 |
| EV to Free Cash Flow | 19.00 | -141.31 | 16.97 | 268.50 | -40.80 |
| EV to Operating Cash Flow | 18.99 | -141.43 | 16.96 | 267.09 | -40.84 |
| Tangible Book Value Per Share | 2.64 | 2.85 | 1.61 | 0.33 | 0.33 |
| Shareholders’ Equity Per Share | 2.64 | 2.85 | 1.61 | 0.33 | 0.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.22 | 0.23 | 1.27 | 0.29 |
| Revenue Per Share | 0.50 | 1.67 | 1.83 | 0.12 | 0.03 |
| Net Income Per Share | 0.24 | 1.11 | 1.24 | 0.00 | -0.07 |
| Tax Burden | 0.78 | 0.78 | 0.77 | -0.27 | 0.71 |
| Interest Burden | 1.77 | 1.04 | 1.03 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.56 | 0.15 | 0.12 | 0.87 | 2.98 |
| SG&A to Revenue | 0.10 | 0.02 | 0.03 | 0.24 | 0.60 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.14 | 0.26 |
| Income Quality | 4.12 | -0.08 | 1.18 | 19.56 | 1.28 |
Currency in AUD

